Kayla Weiss
Gerontology · Saint Louis, MONPI 1174235105
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,349 of the $4,594 with a category attached, or 72.9%. 25 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 35.8% of the total. 2025 is the largest year on record at $2,541, more than ten times the $123 reported in 2022. Among gerontology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $50.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Lilly USA, LLC$409
- AstraZeneca$373
- Amgen$259
- Axsome Therapeutics, Inc.$237
- Novo Nordisk$232
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,14525%
- Food & beverage$3,34973%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $1,645 |
| Lilly USA, LLC | 11 | $409 |
| AstraZeneca | 8 | $373 |
| Amgen | 4 | $259 |
| Axsome Therapeutics, Inc. | 3 | $237 |
| Novo Nordisk | 13 | $232 |
| Edwards Lifesciences | 2 | $153 |
| Harmony Biosciences LLC | 2 | $140 |
| Viiv Healthcare Company | 6 | $132 |
| Boehringer Ingelheim | 2 | $129 |
| AbbVie | 1 | $123 |
| Tris Pharma Inc | 1 | $110 |
| Exact Sciences | 5 | $104 |
| Merck | 2 | $103 |
| Vertos Medical, Inc. | 1 | $94 |
| Idorsia Pharmaceuticals US Inc | 3 | $79 |
| Astellas Pharma US Inc | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Pfizer | 2 | $34 |
| Organon | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Recor Medical Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,288
- Symbravo$125
- MOUNJARO$123
- QULIPTA$123
- UBRELVY$123
- FARXIGA$121
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$120
- JARDIANCE$110
- Dyanavel XR$110
- Quillivant$110
- Quillichew ER$110
- Repatha$102
- FASENRA$101
How this compares
$4,594 in reported general payments places this provider in the 95th percentile of 175 gerontology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $39,340 |
| MounjaroTirzepatide | 20 | $20,729 |
| FarxigaDapagliflozin Propanediol | 18 | $17,019 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,583 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 15 | $978 |
| Metformin Hcl ErMetformin Hcl | 26 | $954 |
| Rosuvastatin Calcium | 43 | $824 |
| Buspirone Hcl | 17 | $467 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $461 |
| Celecoxib | 12 | $411 |
| Diclofenac Sodium | 11 | $320 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $320 |
| Gabapentin | 23 | $271 |
| Meclizine Hcl | 15 | $260 |
| Fluticasone Propionate | 23 | $255 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $232 | $39,34019 claims |
| Lilly USA, LLCMounjaro | $409 | $20,72920 claims |
| AstraZenecaFarxiga | $373 | $17,01918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 175 gerontology providers in Missouri.
Other gerontology in Saint Louis
- Marissa SaengsamranSaint Louis$6K
- Amy GuanSaint Louis$5K
- Michelle CusumanoSaint Louis$4K
- Pibi BoudaSaint Louis$4K
- Allyson ReevesSaint Louis$4K
- Beth YoungerSaint Louis$3K
- Christine KuehnelSaint Louis$3K
- Eileen SteinigerSaint Louis$2K
- Jessica SheehanSaint Louis$2K
- Ellen CarlsonSaint Louis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.